Marksans Pharma Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 866.20 | ||||
| Other Income Qtr Cr | 25.40 | ||||
| Operating Revenues Qtr | 840.80 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 627.76 | ||||
Operating Profit Qtr | 213.04 | ||||
EBITDA Qtr Cr | 238.44 | ||||
Depreciation Qtr | 24.86 | ||||
Net Profit Qtr | 157.17 | ||||
Basic EPS Qtr | 3.47 | ||||